🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a Phase 2, randomized, double-blind, placebo-controlled, multicent...
Status
Terminated
Location
Research Site
Start Date
2007-03-20
Trial ID
NCT00435227
Treatments Being Tested
MI-CP117 was a Phase 3, randomized, double-blind, placebo-controlled trial ...
Status
Completed
Location
Research Site
Start Date
2004-11-15
Trial ID
NCT00121108
Treatments Being Tested
The primary objective of this study was to compare the safety and efficacy ...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2004-11
Trial ID
NCT00129766
Treatments Being Tested
The purpose of this study is to determine the safety of motavizumab (MEDI-5...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00192504
Treatments Being Tested
MEDI-524 given for up to 5 doses at 3 and 15 mg/kg to high-risk children ap...
Status
Completed
Location
Hospital General de Niños "Ricardo Gutierrez"
Start Date
2004-02
Trial ID
NCT00192478
Treatments Being Tested
The primary objective of this study was to determine the effect on immune r...
Status
Completed
Location
Pontificia Universidade Catolica Do Rio Grande
Start Date
2005-05
Trial ID
NCT00113490
Treatments Being Tested
This is a Phase 2, randomized, double-blind study in which motavizumab (MED...
Status
Completed
Location
Department of Paediatrics and Child Health, The Canberra Hospital
Start Date
2006-04
Trial ID
NCT00316264
Treatments Being Tested
The primary objective of this study is to describe the effect of a single d...
Status
Completed
Location
Research Site
Start Date
2007-01-10
Trial ID
NCT00421304
Treatments Being Tested
The primary goal was to describe the safety of the investigational product ...
Status
Completed
Location
Arkansas Pediatric Clinic
Start Date
2005-10
Trial ID
NCT00538785
Treatments Being Tested
The primary objective of this study is to assess the efficacy of motavizuma...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT00628303
Treatments Being Tested